Press Release · Press Releases · Asia-Pacific
VS Pharmtech Boosts Cancer Treatment Efficacy Without Adding Toxicity
SEOUL, South Korea, Nov. 6, 2026 /PRNewswire/ -- Cancer drugs keep improving, but their limits remain. When antibody therapies first emerged, only a fraction of patients benefited, and small-molecule anticancer drugs often carry severe toxicity. Rather than developing a new anticancer...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
NatGold Digital Announces Immediate Delisting of NATG from MEXC Following U.S. Treasury Action
CORAL GABLES, Fla., Nov. 7, 2026 /PRNewswire/ -- NatGold Digital Ltd. ("NatGold" or the "Company") today announced that it has requested the delisting of the NatGold Token (NATG) from MEXC, a global cryptocurrency exchange where NATG is currently listed, with immediate effect. The...
PR Newswire ·
NASA Seeks Next Generation of Explorers to Join Astronaut Corps
NASA is looking for the explorers who will help write the next chapter of human spaceflight. Applications are now open for the agency’s next class of astronauts, who will join NASA as America returns to the Moon, builds the Moon Base, and lays the groundwork for the first crewed missions to Mars. The next generation […]
NASA ·
Off-Broadway Production DUST Raises $30,000 for Young Adults with Autism
LOS ANGELES, Nov. 7, 2026 /PRNewswire/ -- The Off-Broadway production DUST raised $30,000 to support young adults with autism in partnership with Cultural Autism Studies at Yale and the Ed Asner Family Center. The production was staged at the EROS Theatre, in a loft above the historic New...
PR Newswire ·
Routine Invasive Procedures for Stable Heart Disease Offer No Long-Term Survival Advantage Over Drug Therapy
Findings Add to Past Evidence That Early Invasive Procedures Ease Symptoms but Do Not Improve Long-Term Survival NEW YORK, Nov. 7, 2026 /PRNewswire/ -- Patients with stable heart disease and abnormal stress tests who have invasive procedures early in their care do not live longer than...
PR Newswire ·
What to Look for in an Online GLP-1 Provider: Meant Outlines Five Questions Worth Asking Before Signing Up
MANASSAS, Va., Nov. 7, 2026 /PRNewswire/ -- As more telehealth companies offer GLP-1 care, the options can look alike from the outside, and telling them apart takes more than a glance at a landing page. Meant is sharing five questions consumers can ask when choosing an online GLP-1...
PR Newswire ·
Notice of AUR Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Aurora Innovation, Inc. (AUR) Investors to Contact the Firm
RADNOR, Pa., Nov. 7, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Aurora Innovation, Inc. ("Aurora Innovation") (NASDAQ: AUR) on...
PR Newswire ·